Saltar al contenido
Merck
  • The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells.

The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells.

Oncotarget (2015-04-01)
Xin Wan, Ci Cheng, Zhe Lin, Runqiu Jiang, Wei Zhao, Xin Yan, Junwei Tang, Kun Yao, Beicheng Sun, Yun Chen
RESUMEN

Immunotherapy is a promising treatment for liver cancer. Here, we tested the ability of the attenuated hepatocellular carcinoma-specific Listeria vaccine (Lmdd-MPFG) to treat hepatocellular carcinoma (HCC) in a mouse model. Immunization with the vaccine caused a strong anti-tumor response, especially in mice reinfused with dendritic cells (DCs). In mice that were also administered DCs, tumor suppression was accompanied by the strongest cytotoxic T lymphocyte response of all treatment groups and by induced differentiation of CD4+ T cells, especially Th17 cells. Additionally, the Lmdd-MPFG vaccine caused maturation of DCs in vitro. We demonstrated the synergistic effect of TLR4 and NLRP3 or NOD1 signaling pathways in LM-induced DC activation. These results suggest that the Lmdd-MPFG vaccine is a feasible strategy for preventing HCC.

MATERIALES
Product Number
Marca
Descripción del producto

Sigma-Aldrich
Cloruro de amonio, Molecular Biology, suitable for cell culture, ≥99.5%
Sigma-Aldrich
Cloruro de amonio, 99.998% trace metals basis
Sigma-Aldrich
Ácido metilenodifosfónico, ≥99%
Sigma-Aldrich
Cloruro de amonio, 99.99% trace metals basis
Sigma-Aldrich
Cloruro de amonio, BioUltra, ≥99.5% (AT)
Sigma-Aldrich
Ácido metilenodifosfónico, for molecular studies & mass spectrometry
Sigma-Aldrich
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
Sigma-Aldrich
Ammonium-14N chloride, 99.99 atom % 14N, 15N-depleted, 99% (CP)